1. Home
  2. ITRM vs CCM Comparison

ITRM vs CCM Comparison

Compare ITRM & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • CCM
  • Stock Information
  • Founded
  • ITRM 2015
  • CCM 1997
  • Country
  • ITRM Ireland
  • CCM China
  • Employees
  • ITRM N/A
  • CCM N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • CCM Medical/Nursing Services
  • Sector
  • ITRM Health Care
  • CCM Health Care
  • Exchange
  • ITRM Nasdaq
  • CCM Nasdaq
  • Market Cap
  • ITRM 24.7M
  • CCM 25.1M
  • IPO Year
  • ITRM 2018
  • CCM 2009
  • Fundamental
  • Price
  • ITRM $1.37
  • CCM $5.04
  • Analyst Decision
  • ITRM Strong Buy
  • CCM
  • Analyst Count
  • ITRM 1
  • CCM 0
  • Target Price
  • ITRM $5.00
  • CCM N/A
  • AVG Volume (30 Days)
  • ITRM 7.1M
  • CCM 6.1K
  • Earning Date
  • ITRM 11-14-2024
  • CCM 11-29-2024
  • Dividend Yield
  • ITRM N/A
  • CCM N/A
  • EPS Growth
  • ITRM N/A
  • CCM N/A
  • EPS
  • ITRM N/A
  • CCM N/A
  • Revenue
  • ITRM N/A
  • CCM $64,910,622.00
  • Revenue This Year
  • ITRM N/A
  • CCM N/A
  • Revenue Next Year
  • ITRM N/A
  • CCM N/A
  • P/E Ratio
  • ITRM N/A
  • CCM N/A
  • Revenue Growth
  • ITRM N/A
  • CCM N/A
  • 52 Week Low
  • ITRM $0.81
  • CCM $3.80
  • 52 Week High
  • ITRM $2.50
  • CCM $26.70
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 54.25
  • CCM 30.42
  • Support Level
  • ITRM $1.25
  • CCM $4.47
  • Resistance Level
  • ITRM $1.61
  • CCM $5.50
  • Average True Range (ATR)
  • ITRM 0.14
  • CCM 0.69
  • MACD
  • ITRM 0.00
  • CCM -0.27
  • Stochastic Oscillator
  • ITRM 46.67
  • CCM 12.39

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About CCM Concord Medical Services Holdings Limited

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.

Share on Social Networks: